05.05.2017 20:03:00

Johnson & Johnson to Participate in the 2017 UBS Global Healthcare Conference

NEW BRUNSWICK, N.J., May 5, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2017 UBS Global Healthcare Conference on Tuesday, May 23, at the Grand Hyatt New York.  Dominic Caruso, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-2017-ubs-global-healthcare-conference-300452482.html

SOURCE Johnson & Johnson

Analysen zu Johnson & Johnsonmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Johnson & Johnson 139,34 0,06% Johnson & Johnson